Afatinib

afatinib · Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

114 regulatory and trial events tracked for Afatinib, covering 2013-08-30 to 2026-04-01. Get the full timeline:

Most recent: Clinical Trial Update: Study of Afatinib in Advanced Cutaneous Squamous Cell Carcinoma [Phase 2]